Clinical trial
Long Term, Single-arm, Open-label Extension Study of Protocol AC-055-305 to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
NCT01739400 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term, Single-arm, Open-label Extension Study of Protocol AC-055-305 to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
- Lead sponsor
- Actelion
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 10, 2013
- Completion date
- January 12, 2018
- Enrollment
- 217 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.